eNewsroom for: Quantum Immunologics Inc.

http://pressreleaseheadlines.com/wp-content/Cimy_User_Extra_Fields/Quantum Immunologics Inc./quantum.png

Quantum Immunologics Inc. Company Profile

Quantum Immunologics, Inc. (QI) was formed for the sole purpose of developing, implementing and distributing new advanced levels of designer therapeutic treatments and diagnostic tools including all of the patents and intellectual properties acquired from USA by Venture Research Institute, Inc. (a southern California based private investment club) and its sister company, Investors Medical Fund, LLC. QI’s mission is to foster the development and support for these and other technologies that are complementary to its current portfolio of patented intellectual properties that are focused on immune diseases and disorders.

News from Quantum Immunologics Inc.:

Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial

Quantum Immunologics announces the completion of its first clinical treatment injection
TAMPA, Fla., July 13, 2009 — Quantum Immunologics, Inc. (QI), a Tampa, Florida company focusing on the research and development of cancer immunotherapies, announces that the first patient in its breast c…

Immunotherapy-Based Provisional Patents Mark Significant Discovery

Quantum Immunologics announces the filing of two important provisional patent applications
TAMPA, Fla., March 31, 2009 — Quantum Immunologics, Inc. (QI), a Florida-based company specializing in cancer immunotherapy, has recently filed two provisional patent applications relating to the…

Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas

TAMPA, Fla., April 29, 2008 — Quantum Immunologics, Inc. ("QI") announces the commencement of a Phase I/II clinical trial to assess the safety and efficacy of a novel anti-cancer vaccine/immunotherapy that will be used on patients with Stage IV advanced breast cancer. Patients acce…